Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Prevalence of Hepatitis B, Hepatitis C and Associated Risk Factors in Intravenous Drug Addicts (Ivda) With Hiv in Isfahan



Taeri K1 ; Kasaeian N2 ; Nobari RF3 ; Ataei B2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Behavioral Disease Council Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Infectious Disease Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Managing Center Prevention of Diseases, Health Deputy, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Isfahan Medical School Published:2008

Abstract

Background: Viral co-infection is a major cause of human mortality and morbidity and diagnosis of infected patients can lead to prevalence reduction. Methods: In a cross-sectional study, 106 HIV positive patients with a history of IVDA, addmitted among 2000-2007 to Navab-Safavi curing center in Isfahan, were studied. HBs Ag and HCV-Ab were carried on by ELISA method and checklist of related risk factors was completed for each patient. The prevalence of hepatitis B and C and related risk factors were analyzed using Odds Ratio (95% CIs) and logistic Regression tests. Findings: Our result showed that 2 patients (1.8%) had hepatitis B, 80 patients (75.5%) had hepatitis C and 10 patients (9.4%) had both of them. History of imprisonment and unemployment were independent risk factors for IVDA [OR (95% CIs): 18.27 (5.9-56.5) and 8 (2.4-26.1) respectively] but marital status, education and age have not any correlation with neither IVDA nor hepatitis. Conclusion: Our results indicated high prevalence of hepatitis B and C in HIV positive patients with IVDA history. Unemployment and low hygiene in prisons must be mentioned to reduce IVDA in our society. © 2008, Isfahan University of Medical Sciences(IUMS). All rights reserved.
Related Docs
View other Related Docs
1. Hepatitis C in Intravenous Drug Users: Seroprevalence and Risk Factors, Journal of Isfahan Medical School (2011)
2. Hepatitis B and C Among Patients Infected With Human Immunodeficiency Virus in Isfahan, Iran: Seroprevalence and Associated Factors, Hepatitis Monthly (2010)
3. Prevalence and Risk Factors of Hepatitis B Infection in Injection Drug Users, Tehran (2001-2002), Hepatitis Monthly (2008)
4. Seroprevalence of Hepatitis B Markers Among Incarcerated Intravenous Drug Users, Journal of Research in Medical Sciences (2014)
5. Incarceration Is a Major Risk Factor for Blood-Borne Infection Among Intravenous Drug Users, Hepatitis Monthly (2011)
6. Hepatitis C Virus and Associated Risk Factors Among Prison Inmates With History of Drug Injection in Isfahan, Iran, International Journal of Preventive Medicine (2012)
7. Seroprevalence of Hbv, Hcv and Hiv Infection Among Intravenous Drug Users in Shahr-E-Kord, Islamic Republic of Iran, Eastern Mediterranean Health Journal (2008)
8. Hepatitis C Among Intravenous Drug Users in Isfahan, Iran: A Study of Seroprevalence and Risk Factors, International Journal of Preventive Medicine (2012)
Experts (# of related papers)
View all Related Experts
Behrooz Ataei (47)
Zary Nokhodian (33)
Other Related Docs
9. A Case-Control Study of Risk Factors for Hepatitis B Infection: A Regional Report Among Isfahanian Adults, Journal of Research in Medical Sciences (2019)
10. Seroprevalence of and Risk Factors Associated With Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Among Prisoners in Iran, Infectious Diseases in Clinical Practice (2007)
11. The Experience of Hepatitis C Screening Among Prison Inmates With Drug Injection History, Journal of Isfahan Medical School (2011)
12. Hepatitis C Seroprevalence Among Intravenous Drug Users in Tehran, Journal of Research in Medical Sciences (2008)
13. Prevalence of Hbv and Hcv Infections and Associated Risk Factors in Addict Prisoners, Iranian Journal of Public Health (2006)
14. Positive Hepatitis C Virus Antibody in Cases With History of Intravenous Drug Abuse Via Community Announcement: A Useful Experience, Journal of Isfahan Medical School (2011)
15. Occult Hepatitis B Virus Infection Among Human Immunodeficiency Virus-Infected Patients With Isolated Hepatitis B Core Antibody in Isfahan, Iran, Journal of Research in Medical Sciences (2014)
16. Seroprevalence of Hepatitis B Infection and Associated Risk Factors Among Drug Users in Drop-In Centers of Isfahan, Iran, International Journal of Preventive Medicine (2018)
17. Seroprevalence of Hepatitis a in Patients With Chronic Hepatitis C in Isfahan Province, International Journal of Preventive Medicine (2012)
18. Hepatitis B Markers in Isfahan, Central Iran: A Population-Based Study, Hepatitis Monthly (2009)
19. Co-Infection of Human Immunodeficiency Virus, Hepatitis C and Hepatitis B Virus Among Injection Drug Users in Drop in Centers, Journal of Research in Medical Sciences (2014)
20. Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran, Hepatitis Monthly (2017)
21. Prevalence and Risk Factors of Hiv, Syphilis, Hepatitis B and C Among Female Prisoners in Isfahan, Iran, Hepatitis Monthly (2012)
22. Prevalence of Hepatitis B Virus Infection in Isfahan Province, International Journal of Preventive Medicine (2014)
23. Risk Prison and Hepatitis B Virus Infection Among Inmates With History of Drug Injection in Isfahan, Iran, The Scientific World Journal (2013)
24. Seroprevalence of Hepatitis B in Nahavand, Islamic Republic of Iran, Eastern Mediterranean Health Journal (2006)
25. Assessment of Hepatitis C Risk Factors in Center of Iran: A Case-Control Study, Journal of Research in Medical Sciences (2018)
26. Seroprevalence of Hepatitis B Virus Infection and Hepatitis B Surface Antibody Status Among Laboratory Health Care Workers in Isfahan, Iran, Asian Journal of Transfusion Science (2015)
27. Hepatitis D Virus Infection in Isfahan, Central Iran: Prevalence and Risk Factors Among Chronic Hbv Infection Cases, Hepatitis Monthly (2011)
28. Prevalence and Risk Factors for Hepatitis B and Hepatitis C Exposure in Iranian Prisoners: A National Study in 2016, Hepatitis Monthly (2019)
29. Correlation Between Il-28 Polymorphism and Spontaneous Clearance in Hcv Patients: Systematic Review and Meta-Analysis, Archives of Virology (2021)
30. Identification of Histopathologic Criteria to Differentiate Autoimmune Hepatitis (Aih) From Chronic Viral Hepatitis (B, C) in Liver Biopsy Samples, Journal of Isfahan Medical School (2017)
31. Prevalence of Hepatitis C Virus, Hepatitis B Virus, Human Immunodeficiency Virus and Related Risk Factors Among Hemophilia and Thalassemia Patients in Iran, Iranian Journal of Clinical Infectious Diseases (2011)
32. Occult Hepatitis B Virus Infection Among Blood Donors With Antibodies to Hepatitis B Core Antigen, Acta Medica Iranica (2008)
33. Hepatitis C Screening in Intravenous Drug Users Under Treatment With Methadone: An Action Reserch Study, Journal of Isfahan Medical School (2011)
34. Comparison of the Prevalence and Risk Factors of Hepatitis a in 10 to 18-Year-Old Adolescents of Sixteen Iranian Provinces: The Caspian-Iii Study, Hepatitis Monthly (2016)
35. Global, Regional, and National Burden of Hepatitis B, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
36. Comparing the Effectiveness of a Short-Term Double-Dose Hepatitis B Vaccination Schedule With the Standard 3-Dose Schedule: A Randomized Clinical Trial, Tehran University Medical Journal (2011)
37. Review of Hepatocellular Carcinoma and Liver Disease Prevalence, New Emirates Medical Journal (2024)
38. Seroprevalence of Hepatitis a Among Street Children, Isfahan, Iran, Journal of Isfahan Medical School (2012)
39. Prevalence of Hiv Infection and Related Risk Factors in Isfahan Drop in Centers, Pakistan Journal of Medical Sciences (2013)
40. Interleukin-28B (Rs12979860) Gene Variation and Treatment Outcome After Peginterferon Plus Ribavirin Therapy in Patients With Genotype 1 of Hepatitis C Virus, Journal of Research in Medical Sciences (2014)
41. Analysis of the Related Factors in Hepatitis C Virus Infection Among Hemophilic Patients in Isfahan, Iran, Hepatitis Monthly (2007)
42. High Risky Behaviors Among Intravenous Drug Users in Isfahan, Iran: A Study for Hepatitis C Harm Reduction Programs, International Journal of Preventive Medicine (2012)
43. Seroepidemiology of Hepatitis a Virus Infections in Over 6-Years Population in Isfahan–Iran: A Community-Based Study, Journal of Isfahan Medical School (2007)
44. Occult Hepatitis B Among Iranian Hepatitis C Patients, Journal of Research in Medical Sciences (2009)
45. Seroprevalence of Hepatitis a Virus in Patients With Chronic Hepatitis B or C in Isfahan Province, Iran, Journal of Isfahan Medical School (2012)
46. Comparison of Hbs-Antibody Serum Levels Between Patients With Type 2 Diabetes Mellitus and Controls Following Vaccination Against Hepatitis B, Journal of Isfahan Medical School (2007)
47. Seroprevalence of Hepatitis B Virus and Human Immunodeficiency Virus Among Young Prisoners, Journal of Research in Medical Sciences (2013)
48. Prevalence of Hiv/Hcv/Hbv Infections and Drug-Related Risk Behaviours Amongst Idus Recruited Through Peer-Driven Sampling in Iran, International Journal of Drug Policy (2010)
49. Hepatitis C Screening in Intravenuos Drug Users in Golpayegan, Isfahan Through Community Announcement: Pilot Study, Journal of Isfahan Medical School (2011)
50. Hepatitis C in Correctional Centers: A Useful Experience, Journal of Isfahan Medical School (2011)